Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhPSA DNA Vaccine with Electroporation for Relapsed Prostate Cancer
NCT00859729Phase 2Completed
- Sponsor
- Uppsala University
- Start
- Dec 2008
- Primary completion
- Nov 2011
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of pVAXrcPSAv53I in prostate cancer (PCa), sponsored by Uppsala University. Started Dec 2008; status: completed.
02
Drugs
pVAXrcPSAv53I
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00859729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859729.